These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 27151755)
1. Efficacy of Topical Recombinant Human Epidermal Growth Factor for Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis. Yang S; Geng Z; Ma K; Sun X; Fu X Int J Low Extrem Wounds; 2016 Jun; 15(2):120-5. PubMed ID: 27151755 [TBL] [Abstract][Full Text] [Related]
2. Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials. Yang Q; Zhang Y; Yin H; Lu Y Ann Vasc Surg; 2020 Jan; 62():442-451. PubMed ID: 31394225 [TBL] [Abstract][Full Text] [Related]
3. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial. Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542 [TBL] [Abstract][Full Text] [Related]
4. Epidermal Growth Factor is Effective in the Treatment of Diabetic Foot Ulcers: Meta-Analysis and Systematic Review. Bui TQ; Bui QVP; Németh D; Hegyi P; Szakács Z; Rumbus Z; Tóth B; Emri G; Párniczky A; Sarlós P; Varga O Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31331038 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of recombinant human epidermal growth factor for diabetic foot ulcers: A systematic review and meta-analysis of randomised controlled trials. Zhao DY; Su YN; Li YH; Yu TQ; Li J; Tu CQ Int Wound J; 2020 Aug; 17(4):1062-1073. PubMed ID: 32343054 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical recombinant human platelet-derived growth factor for treatment of diabetic lower-extremity ulcers: Systematic review and meta-analysis. Zhao XH; Gu HF; Xu ZR; Zhang Q; Lv XY; Zheng XJ; Yang YM Metabolism; 2014 Oct; 63(10):1304-13. PubMed ID: 25060693 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of hyaluronic acid for treating diabetic foot: a systematic review and meta-analysis. Chen CP; Hung W; Lin SH Dermatol Ther; 2014; 27(6):331-6. PubMed ID: 25039587 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis. Rahim F; Yan X; Shah JA; Bibi N; Khan ZU; Nawaz S; Ming Y F1000Res; 2022; 11():773. PubMed ID: 37867626 [No Abstract] [Full Text] [Related]
12. Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats. Chu Y; Yu D; Wang P; Xu J; Li D; Ding M Wound Repair Regen; 2010; 18(5):499-505. PubMed ID: 20840519 [TBL] [Abstract][Full Text] [Related]
13. The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse. Hardwicke JT; Hart J; Bell A; Duncan R; Thomas DW; Moseley R J Control Release; 2011 Jun; 152(3):411-7. PubMed ID: 21435363 [TBL] [Abstract][Full Text] [Related]
14. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success. Saco M; Howe N; Nathoo R; Cherpelis B Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934 [TBL] [Abstract][Full Text] [Related]
15. Controlled release of epidermal growth factor from hydrogels accelerates wound healing in diabetic rats. Lao G; Yan L; Yang C; Zhang L; Zhang S; Zhou Y J Am Podiatr Med Assoc; 2012; 102(2):89-98. PubMed ID: 22461265 [TBL] [Abstract][Full Text] [Related]
16. The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers. Buchberger B; Follmann M; Freyer D; Huppertz H; Ehm A; Wasem J GMS Health Technol Assess; 2010 Sep; 6():Doc12. PubMed ID: 21289885 [TBL] [Abstract][Full Text] [Related]
17. Improving Diabetic Wound-Healing Outcomes With Topical Growth Factor Therapies. Wong AYW; Hooi NMF; Yeo BSY; Sultana R; Bee YM; Lee ARYB; Tay SM J Clin Endocrinol Metab; 2024 Jul; 109(8):e1642-e1651. PubMed ID: 38477463 [TBL] [Abstract][Full Text] [Related]
18. Polyurethane foam containing rhEGF as a dressing material for healing diabetic wounds: Synthesis, characterization, in vitro and in vivo studies. Pyun DG; Choi HJ; Yoon HS; Thambi T; Lee DS Colloids Surf B Biointerfaces; 2015 Nov; 135():699-706. PubMed ID: 26340359 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of the effects of recombinant human epidermal growth factor and basic fibroblast growth factor on corneal epithelial wound healing and neovascularization in vivo and in vitro. Yan L; Wu W; Wang Z; Li C; Lu X; Duan H; Zhou J; Wang X; Wan P; Song Y; Tang J; Han Y Ophthalmic Res; 2013; 49(3):150-60. PubMed ID: 23258255 [TBL] [Abstract][Full Text] [Related]
20. The Role of Recombinant Proteins and Growth Factors in the Management of Diabetic Foot Ulcers: A Systematic Review of Randomized Controlled Trials. Mahdipour E; Sahebkar A J Diabetes Res; 2020; 2020():6320514. PubMed ID: 32733969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]